Precision medicine for suicidality: From universality to subtypes and personalization

Molecular Psychiatry

Volumn 22, Issue 9, 2017, Pages 1250-1273

  Niculescu, A B ^a,b   Le Niculescu, H ^a   Levey, D F ^a   Phalen, P L ^b   Dainton, H L ^a   Roseberry, K ^a   Niculescu, E M ^a   Niezer, J O ^a   Williams, A ^b   Graham, D L ^b   Jones, T J ^b   Venugopal, V ^a   Ballew, A ^c   Yard, M ^a   Gelbart, T ^d   Kurian, S M ^d   Shekhar, A ^a   Schork, N J ^e   Sandusky, G E ^a   Salomon, D R ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Marion County Prosecutor's Office   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANXIETY DISORDER; BIPOLAR DISORDER; BLOOD; DEPRESSION; FEMALE; GENE EXPRESSION; GENETICS; GENOMICS; HUMAN; MALE; PERSONALIZED MEDICINE; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

ADULT; ANXIETY DISORDERS; BIOMARKERS; BIPOLAR DISORDER; DEPRESSION; FEMALE; GENE EXPRESSION; GENOMICS; HUMANS; MALE; PRECISION MEDICINE; RISK ASSESSMENT; RISK FACTORS; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED;

EID: 85027841611     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.128     Document Type: Article

References (66)

1. Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME et al. Toward a biosignature for suicide. Am J Psychiatry 2014; 171: 1259-1277.
2. Niculescu AB, Levey D, Le-Niculescu H, Niculescu E, Kurian SM, Salomon D. Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions. Mol Psychiatry 2015; 20: 286-288.
3. Niculescu AB. A brief proposal for improving clinical trials. Mol Psychiatry 2016; 21: 736-737.
4. Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry 2015; 20: 1266-1285.
5. Levey DF, Niculescu EM, Le-Niculescu H, Dainton HL, Phalen PL, Ladd TB et al. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment. Mol Psychiatry 2016; 21: 768-785.
6. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Miriami E et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148: 1293-1307.
7. Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 2013; 18: 1249-1264.
8. Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ et al. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 653-662.
9. Borges G, Angst J, Nock MK, Ruscio AM, Kessler RC. Risk factors for the incidence and persistence of suicide-related outcomes: a 10-year follow-up study using the National Comorbidity Surveys. J Affect Disord 2008; 105: 25-33.
10. Nock MK. Future directions for the study of suicide and self-injury. J Clin Child Adoslesc Psychol 2012; 41: 255-259.
11. Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005; 14: 241-253.
12. Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J et al. Phenomic, convergent functional genomic, and biomarker studies in a stressreactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 134-166.
13. McCarthy MJ, Welsh DK. Cellular circadian clocks in mood disorders. J Biol Rhythms 2012; 27: 339-352.
14. Goodwin RD, Marusic A. Association between short sleep and suicidal ideation and suicide attempt among adults in the general population. Sleep 2008; 31: 1097-1101.
15. Singh N, Sharpley AL, Emir UE, Masaki C, Herzallah MM, Gluck MA et al. Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans. Neuropsychopharmacology 2016; 41: 1768-1778.
16. Azad GK, Tomar RS. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways. Mol Biol Rep 2014; 41: 4865-4879.
17. Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev 2005; 11: 169-182.
18. Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 2008; 138: 2309-2315.
19. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M et al. Metformin improves healthspan and lifespan in mice. Nat Commun 2013; 4: 2192.
20. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS ONE 2012; 7: e35367.
21. Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med 2016; 22: 1428-1438.
22. Rangaraju S, Levey DF, Nho K, Jain N, Andrews KD, Le-Niculescu H et al. Mood, stress and longevity: convergence on ANK3. Mol Psychiatry 2016; 21: 1037-1049.
23. Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry 2016; 173: 816-826.
24. Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 2015; 45: 3571-3580.
25. O'Brien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT et al. Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice. J Clin Invest 2011; 121: 3756-3762.
26. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308: 512-517.
27. Claassen CA, Pearson JL, Khodyakov D, Satow PM, Gebbia R, Berman AL et al. Reducing the burden of suicide in the U. S.: the aspirational research goals of the National Action Alliance for Suicide Prevention Research Prioritization Task Force. Am J Prevent Med 2014; 47: 309-314.
28. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology 2013; 38: 1504-1511.
29. Brezo J, Bureau A, Merette C, Jomphe V, Barker ED, Vitaro F et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry 2010; 15: 831-843.
30. Giegling I, Hartmann AM, Moller HJ, Rujescu D. Anger-and aggression-related traits are associated with polymorphisms in the 5-HT-2 A gene. J Affect Disord 2006; 96: 75-81.
31. Vaquero-Lorenzo C, Baca-Garcia E, Diaz-Hernandez M, Perez-Rodriguez MM, Fernandez-Navarro P, Giner L et al. Association study of two polymorphisms of the serotonin-2 A receptor gene and suicide attempts. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 645-649.
32. Shinozaki G, Romanowicz M, Mrazek DA, Kung S. HTR2 A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients. J Affect Disord 2013; 150: 1200-1203.
33. Gonzalez-Castro TB, Tovilla-Zarate C, Juarez-Rojop I, Pool Garcia S, Velazquez-Sanchez MP, Genis A et al. Association of the 5HTR2 A gene with suicidal behavior: case-control study and updated meta-analysis. BMC Psychiatry 2013; 13: 25.
34. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M et al. Prediction of level of serotonin 2 A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999; 156: 1456-1458.
35. Escriba PV, Ozaita A, Garcia-Sevilla JA. Increased mRNA expression of alpha2Aadrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 2004; 29: 1512-1521.
36. Anisman H, Du L, Palkovits M, Faludi G, Kovacs GG, Szontagh-Kishazi P et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 2008; 33: 131-141.
37. Malone KM, Ellis SP, Currier D, John Mann J. Platelet 5-HT2A receptor subresponsivity and lethality of attempted suicide in depressed in-patients. Int J Neuropsychopharmacol 2007; 10: 335-343.
38. Guintivano J, Brown T, Newcomer A, Jones M, Cox O, Maher BS et al. Identification and replication of a combined epigenetic and genetic biomarker predicting suicide and suicidal behaviors. Am J Psychiatry 2014; 171: 1287-1296.
39. Kaminsky Z, Wilcox HC, Eaton WW, Van Eck K, Kilaru V, Jovanovic T et al. Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder. Transl Psychiatry 2015; 5: e627.
40. Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF et al. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry 2010; 167: 1499-1507.
41. Kim S, Choi KH, Baykiz AF, Gershenfeld HK. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007; 8: 413.
42. Omrani MD, Bushehri B, Bagheri M, Salari-Lak S, Alipour A, Anoshae MR et al. Role of IL-10-1082, IFN-gamma +874, and TNF-alpha-308 genes polymorphisms in suicidal behavior. Arch Suicide Res 2009; 13: 330-339.
43. Labonte B, Suderman M, Maussion G, Lopez JP, Navarro-Sanchez L, Yerko V et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry 2013; 170: 511-520.
44. Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 356-361.
45. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006; 63: 35-48.
46. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of HTR2A in suicide attempts: observed gene, gene x environment and parent-oforigin associations. Mol Psychiatry 2013; 18: 758-766.
47. Wasserman D, Wasserman J, Rozanov V, Sokolowski M. Depression in suicidal males: genetic risk variants in the CRHR1 gene. Genes Brain Behav 2009; 8: 72-79.
48. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Gene-environment interactions between CRHR1 variants and physical assault in suicide attempts. Genes Brain Behav 2011; 10: 663-672.
49. Roy A, Hodgkinson CA, Deluca V, Goldman D, Enoch MA. Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 2012; 46: 72-79.
50. Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW et al. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001; 6: 540-546.
51. Thalmeier A, Dickmann M, Giegling I, Schneider B, Hartmann A M, Maurer K et al. Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 2008; 11: 217-228.
52. Fiori LM, Wanner B, Jomphe V, Croteau J, Vitaro F, Tremblay RE et al. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS ONE 2010; 5: e15146.
53. Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry 2013; 18: 985-992.
54. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, ffrench-Mullen J et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009; 14: 175-189.
55. Fiori LM, Turecki G. Epigenetic regulation of spermidine/spermine N1-acetyltransferase (SAT1) in suicide. J Psychiatr Res 2011; 45: 1229-1235.
56. Fiori LM, Mechawar N, Turecki G. Identification and characterization of spermidine/ spermine N1-acetyltransferase promoter variants in suicide completers. Biol Psychiatry 2009; 66: 460-467.
57. Pantazatos SP, Andrews SJ, Dunning-Broadbent J, Pang J, Huang YY, Arango V et al. Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol Dis 2015; 79: 123-134.
58. Hill EJ, Nagel DA, O'Neil JD, Torr E, Woehrling EK, Devitt A et al. Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS ONE 2013; 8: e58822.
59. Steward LJ, Kennedy MD, Morris BJ, Pratt JA. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors. Neuropharmacology 2004; 47: 527-537.
60. Williams AA, Ingram WM, Levine S, Resnik J, Kamel CM, Lish JR et al. Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology 2012; 37: 2285-2298.
61. Mondelli V, Ciufolini S, Belvederi Murri M, Bonaccorso S, Di Forti M, Giordano A et al. Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr Bull 2015; 41: 1162-1170.
62. Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 2004; 9: 1007-1029.
63. Oved K, Morag A, Pasmanik-Chor M, Rehavi M, Shomron N, Gurwitz D. Genomewide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Transl Psychiatry 2013; 3: e313.
64. Le-Niculescu H, Case NJ, Hulvershorn L, Patel SD, Bowker D, Gupta J et al. Convergent functional genomic studies of omega-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Transl Psychiatry 2011; 1: e4.
65. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313: 1929-1935.
66. Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007; 7: 54-60.